“The Evaluation of SATB2 As a Diagnostic Immunohistochemical Marker of Colorectal Adenocarcinoma in Comparison With Non-Colorectal Adenocarcinomas”. Journal of Pharmaceutical Negative Results, Feb. 2023, pp. 2280-9, https://doi.org/10.47750/pnr.2023.14.02.278.